Studies demonstrate that expression levels of the intestinal tight junction proteins Occludin, Claudin-1, and ZO-1 are significantly reduced in NAFLD patients compared to healthy subjects [57]. This evidence concerns the gene OCLN and metabolic dysfunction-associated steatotic liver disease.